Klaus Seppi

39.7k total citations · 8 hit papers
296 papers, 21.1k citations indexed

About

Klaus Seppi is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Klaus Seppi has authored 296 papers receiving a total of 21.1k indexed citations (citations by other indexed papers that have themselves been cited), including 254 papers in Neurology, 97 papers in Cellular and Molecular Neuroscience and 34 papers in Neurology. Recurrent topics in Klaus Seppi's work include Parkinson's Disease Mechanisms and Treatments (230 papers), Neurological disorders and treatments (165 papers) and Genetic Neurodegenerative Diseases (78 papers). Klaus Seppi is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (230 papers), Neurological disorders and treatments (165 papers) and Genetic Neurodegenerative Diseases (78 papers). Klaus Seppi collaborates with scholars based in Austria, United States and Italy. Klaus Seppi's co-authors include Werner Poewe, Gregor K. Wenning, Glenda M. Halliday, Anette Schrag, Anthony E. Lang, Caroline M. Tanner, Patrik Brundin, Jens Volkmann, Michael Schocke and Cristina Sampaio and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Klaus Seppi

285 papers receiving 20.7k citations

Hit Papers

Parkinson disease 2008 2026 2014 2020 2017 2008 2011 2018 2019 1000 2.0k 3.0k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Klaus Seppi 16.3k 6.0k 2.7k 2.6k 2.5k 296 21.1k
Wolfgang H. Oertel 15.9k 1.0× 6.0k 1.0× 3.6k 1.3× 3.1k 1.2× 2.8k 1.1× 292 23.4k
Angelo Antonini 15.8k 1.0× 5.4k 0.9× 3.5k 1.3× 1.8k 0.7× 1.4k 0.6× 529 21.0k
Eduardo Tolosa 19.8k 1.2× 6.5k 1.1× 4.7k 1.7× 3.6k 1.4× 4.0k 1.6× 386 26.6k
Charles H. Adler 19.5k 1.2× 5.3k 0.9× 4.3k 1.6× 2.9k 1.1× 4.7k 1.9× 313 25.7k
Olivier Rascol 20.8k 1.3× 7.7k 1.3× 4.7k 1.7× 3.0k 1.2× 2.1k 0.8× 434 27.5k
Anette Schrag 16.6k 1.0× 4.5k 0.7× 3.1k 1.1× 2.4k 0.9× 2.1k 0.8× 308 22.4k
Thomas Foltynie 15.4k 0.9× 7.4k 1.2× 4.6k 1.7× 2.6k 1.0× 2.6k 1.0× 284 20.6k
José Á. Obeso 21.1k 1.3× 10.8k 1.8× 5.3k 1.9× 3.8k 1.5× 2.5k 1.0× 308 29.1k
J. Eric Ahlskog 13.3k 0.8× 5.2k 0.9× 2.4k 0.9× 2.2k 0.9× 2.6k 1.0× 279 19.9k
Paolo Barone 12.3k 0.8× 4.2k 0.7× 3.4k 1.2× 1.5k 0.6× 1.3k 0.5× 418 17.6k

Countries citing papers authored by Klaus Seppi

Since Specialization
Citations

This map shows the geographic impact of Klaus Seppi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Seppi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Seppi more than expected).

Fields of papers citing papers by Klaus Seppi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Seppi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Seppi. The network helps show where Klaus Seppi may publish in the future.

Co-authorship network of co-authors of Klaus Seppi

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Seppi. A scholar is included among the top collaborators of Klaus Seppi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Seppi. Klaus Seppi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walton‐Doyle, Caitlin, Beatrice Heim, Eleanor Sinclair, et al.. (2025). Classification of Parkinson’s disease and isolated REM sleep behaviour disorder: delineating progression markers from the sebum volatilome. npj Parkinson s Disease. 11(1). 202–202. 1 indexed citations
2.
Kawabata, Kazuya, Florian Krismer, Mizuki Ito, et al.. (2025). Trajectories of Pontine Volume in Patients with Multiple System Atrophy. Movement Disorders. 40(7). 1369–1378. 1 indexed citations
3.
Rivasi, Giulia, Hans H. Goebel, Giuseppe Dario Testa, et al.. (2025). Delayed orthostatic hypotension in Parkinson’s disease and in the general ageing population. Age and Ageing. 54(7).
4.
Schmutzhard, Joachim, Marina Peball, Atbin Djamshidian, et al.. (2025). Protocol for olfactory training in persisting COVID-19-associated loss of smell (SMELL): a monocentric randomised controlled trial conducted in Innsbruck. BMJ Open. 15(5). e094027–e094027. 1 indexed citations
5.
Raccagni, Cecilia, Anisoara Paraschiv-Ionescu, Nils Roth, et al.. (2024). Effects of physiotherapy and home-based training in parkinsonian syndromes: protocol for a randomised controlled trial (MobilityAPP). BMJ Open. 14(5). e081317–e081317. 3 indexed citations
6.
Kawabata, Kazuya, Epifanio Bagarinao, Klaus Seppi, & Werner Poewe. (2024). Longitudinal brain changes in Parkinson's disease with severe olfactory deficit. Parkinsonism & Related Disorders. 122. 106072–106072. 5 indexed citations
7.
Beliveau, Vincent, Florian Krismer, Marina Peball, et al.. (2024). Long‐Term Medication Profiles in Parkinson's Disease under Subthalamic Deep Brain Stimulation: A Controlled Study. Movement Disorders Clinical Practice. 11(7). 855–860. 1 indexed citations
8.
Kawabata, Kazuya, Atbin Djamshidian, Epifanio Bagarinao, et al.. (2023). Cognitive dysfunction in de novo Parkinson disease: Remitting vs. progressive cognitive impairment. Parkinsonism & Related Disorders. 120. 105984–105984. 4 indexed citations
9.
Eschlboeck, Sabine, Hans H. Goebel, Alessandra Fanciulli, et al.. (2023). Development and Validation of a Prognostic Model to Predict Overall Survival in Multiple System Atrophy. Movement Disorders Clinical Practice. 10(9). 1368–1376. 4 indexed citations
10.
Krismer, Florian, Marina Peball, Atbin Djamshidian, et al.. (2023). α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis. Movement Disorders Clinical Practice. 10(5). 737–747. 55 indexed citations
11.
Krismer, Florian, Patrice Péran, Vincent Beliveau, et al.. (2023). Progressive Brain Atrophy in Multiple System Atrophy: A Longitudinal, Multicenter, Magnetic Resonance Imaging Study. Movement Disorders. 39(1). 119–129. 12 indexed citations
12.
Fasano, Alfonso, Victor S.C. Fung, Klaus Seppi, et al.. (2022). Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study. Acta Neurologica Scandinavica. 146(2). 167–176. 7 indexed citations
13.
Deuschl, Günther, Angelo Antonini, João Costa, et al.. (2022). European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies. Movement Disorders. 37(7). 1360–1374. 100 indexed citations breakdown →
14.
Deuschl, Günther, Angelo Antonini, João Costa, et al.. (2022). European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies. European Journal of Neurology. 29(9). 2580–2595. 48 indexed citations
15.
Beliveau, Vincent, Martin Nørgaard, Christoph Birkl, Klaus Seppi, & Christoph Scherfler. (2021). Automated segmentation of deep brain nuclei using convolutional neural networks and susceptibility weighted imaging. Human Brain Mapping. 42(15). 4809–4822. 16 indexed citations
16.
Seppi, Klaus, Rossella Medori, Petra Lührs, et al.. (2021). Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study. Journal of Parkinson s Disease. 11(3). 1079–1089. 44 indexed citations
17.
Reimão, Sofia, et al.. (2020). A Standardized MR Imaging Protocol for Parkinsonism. Movement Disorders. 35(10). 1745–1750. 7 indexed citations
18.
Nigro, Salvatore, Angelo Antonini, David E. Vaillancourt, et al.. (2020). Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study. Movement Disorders. 35(6). 976–983. 35 indexed citations
19.
Gilman, Sid, Gregor K. Wenning, David J. Brooks, et al.. (2008). Second consensus statement on the diagnosis of multiple system atrophy. UCL Discovery (University College London). 6 indexed citations
20.
Brenneis, Christian, Klaus Seppi, Michael Schocke, et al.. (2004). Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy.. PubMed Central. 75(2). 246–9. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026